Clinical Trial Co. CEO Can't Avoid Fraud Charges Over Delay
A case against the CEO of a Miami clinical trial company indicted in a scheme to falsify research and defraud drugmakers will move forward after a federal judge rejected her claim...To view the full article, register now.
Already a subscriber? Click here to view full article